Development and Validation of a Claims-Based Measure as an Indicator for Disease Status in Patients with Multiple Sclerosis Treated with Disease-Modifying Drugs
An Evaluation of Adherence in Patients with Multiple Sclerosis Newly Initiating Treatment with a Self-Injectable or an Oral Disease-Modifying Drug
Rates of Pregnancy Among Women with Multiple Sclerosis over time by Age, Region, and Payer: A US Retrospective Claims Database Analysis
Comparing Instant Health Data and SAS for Evaluation of Incidence Rates in Multiple Sclerosis Using MarketScan
An Assessment of Factors Associated with High Costs Among Patients with Multiple Sclerosis (MS) Receiving Disease-Modifying Drug (DMD) Therapy
An Assessment of Adherence Among Multiple Sclerosis Patients Newly Initiating Treatment with a Self-Injectable Versus Oral Disease-Modifying Drug
A Descriptive Analysis of Time to First Treatment with Disease-Modifying Drugs in Newly Diagnosed Patients with Multiple Sclerosis
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database